piretanide has been researched along with Nephrosis in 1 studies
piretanide: potent inhibitor of chloride transport; structure
Nephrosis: Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sjöström, P | 1 |
1 other study available for piretanide and Nephrosis
| Article | Year |
|---|---|
Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
Topics: Adult; Diuresis; Diuretics; Drug Tolerance; Female; Furosemide; Humans; Kidney; Kidney Failure, Chro | 1988 |